Multiprofile Hospital for Active Treatment Sveta Marina EAD
Varna 9010
0 studies enrolling now · 10 studies all time
What they study most
Beta-Thalassemia, Cushing Syndrome, Erythrocyte Transfusion, Hepatocellular Carcinoma, Leukemia, Myeloid, Acute, Multiple Sclerosis, Parkinson's Disease, Respiratory Syncytial Virus Infections, Ulcerative Colitis, Urothelial Cancer
Studies at this site
- Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome — Recruiting now
- A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
- Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) — Stopped early
- SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
- An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia — Completed
- Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) — Completed
- Efficacy and Safety Study of Ozanimod in Ulcerative Colitis — Completed
- Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
- Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis — Completed
- A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients — Status unconfirmed